Avulux
Brant Southwell serves as the Chief Commercial Officer at Avulux and has previously held the position of Strategic Advisor at Sanitas Advisors. With a strong background in marketing, Brant Southwell has also excelled as the Vice President of Marketing at both Neurolens and Savoya, demonstrating significant expertise in driving commercial success and strategic initiatives within organizations.
This person is not in any teams
This person is not in any offices
Avulux
Nearly 2 of every 10 patients an Optometrist sees each day is living with a debilitating disorder called migraine. Even more are living with light sensitivity. Avulux manufactures Avulux Migraine & Light Sensitivity Lenses – a new generation of precision optical filter. Unlike other “migraine” or “neurological” lenses, Avulux Migraine & Light Sensitivity Lenses are clinically proven to help people living with migraine. In fact, Avulux has commissioned two independent studies that demonstrate the superior efficacy of our patented light filtering technology. Avulux Migraine & Light Sensitivity Lenses precisely filter up to 97% of harmful blue, red and amber light while allowing soothing green light through. Actively supporting people living with migraine and light sensitivity is central to everything we do – it’s in our DNA. We are inspired by their stories and motivated by their courage. By delivering clinically-proven, best-in-class therapeutic lens technology, our ambition is to help them reclaim life on their terms. Optometrists in the U.S., Canada, Australia, and New Zealand, can learn about becoming an Avulux Authorized Provider by visiting https://ecp.avulux.com.